Diagnosis and Treatment of Patients With Cystic Fibrosis

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH)

Overall Status

Recruiting

CT.gov ID

NCT00001223

Collaborator

(none)

9,999

Enrollment

Location

Study Details

Study Description

Brief Summary

This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis.

Condition or Disease	Intervention/Treatment	Phase
Cystic Fibrosis Liver Disease or Abnormalities Diabetes Pancreatic Insufficiency (Exocrine and Endocrine)

Detailed Description

Study Design

Study Type:

Observational

Anticipated Enrollment :

9999 participants

Observational Model:

Cohort

Time Perspective:

Prospective

Official Title:

Diagnosis and Treatment of Patients With Cystic Fibrosis

Actual Study Start Date :

Jan 1, 1988

Arms and Interventions

Arm	Intervention/Treatment
CF Patients cystic fibrosis patients
CF Relatives relatives of cystic fibrosis patients

Outcome Measures

Primary Outcome Measures

To develop a database and collection of samples obtained from patients with CF during their clinical care to allow for future research [end of study]
To develop a collection of samples and a database from patients with cystic fibrosis to be used in future research.

Eligibility Criteria

Criteria

Ages Eligible for Study:

4 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

INCLUSION CRITERIA
Patients with known or suspected CF and family members of patients with CF.
=4 years of age

EXCLUSION CRITERIA

-Concomitant medical, psychiatric or other problems which might complicate interpretation of studies of CF, or for which we are unable to provide adequate care.